Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

被引：47

作者：

Abu-Raddad, Laith J. ^{[1
,2
,3
]}

Chemaitelly, Hiam ^{[1
,2
]}

Yassine, Hadi M. ^{[4
,5
]}

Benslimane, Fatiha M. ^{[4
,5
]}

Al Khatib, Hebah A. ^{[4
,5
]}

Tang, Patrick ^{[6
]}

Malek, Joel A. ^{[7
,8
]}

Coyle, Peter ^{[4
,9
,10
]}

Ayoub, Houssein H. ^{[11
]}

Al Kanaani, Zaina ^{[9
]}

Al Kuwari, Einas ^{[9
]}

Jeremijenko, Andrew ^{[9
]}

Kaleeckal, Anvar Hassan ^{[9
]}

Latif, Ali Nizar ^{[9
]}

Shaik, Riyazuddin Mohammad ^{[9
]}

Abdul Rahim, Hanan F. ^{[12
]}

Nasrallah, Gheyath K. ^{[7
,8
]}

Al Kuwari, Mohamed Ghaith ^{[13
]}

Al Romaihi, Hamad Eid ^{[14
]}

Al-Thani, Mohamed H. ^{[14
]}

Al Khal, Abdullatif ^{[9
]}

Butt, Adeel A. ^{[3
,9
]}

Bertollini, Roberto ^{[14
]}

机构：

[1] Cornell Univ, Weill Cornell Med Qatar, Infect Dis Epidemiol Grp, Doha, Qatar

[2] Cornell Univ, Collaborating Ctr Dis Epidemiol Analyt HIV AIDS, Sexually Transmitted Infect & Viral Hepatitis,Wor, Weill Cornell Med Qatar,Qatar Fdn Educ City, Doha, Qatar

[3] Cornell Univ, Weill Cornell Med, Dept Populat Hlth Sci, New York, NY 10021 USA

[4] Qatar Univ, QU Hlth, Biomed Res Ctr, Doha, Qatar

[5] Qatar Univ, QU Hlth, Coll Hlth Sci, Dept Biomed Sci, Doha, Qatar

[6] Sidra Med, Dept Pathol, Doha, Qatar

[7] Cornell Univ, Weill Cornell Med Qatar, Genom Lab, Doha, Qatar

[8] Cornell Univ, Weill Cornell Med Qatar, Dept Genet Med, Doha, Qatar

[9] Hamad Med Corp, Doha, Qatar

[10] Queens Univ, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland

[11] Qatar Univ, Dept Math Stat & Phys, Doha, Qatar

[12] Qatar Univ, QU Hlth, Coll Hlth Sci, Doha, Qatar

[13] Primary Hlth Care Corp, Doha, Qatar

[14] Minist Publ Hlth, Doha, Qatar

来源：

JOURNAL OF TRAVEL MEDICINE | 2021年 / 28卷 / 07期

关键词：

SARS-CoV-2; alpha variant; beta variant; delta variant; B1.617.2; B1.1.7;

D O I：

10.1093/jtm/taab083

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页数：4

共 50 条

[1] Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine
Ganzel, Chezi
Ben-Chetrit, Eli
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (06): : 341 - 341
[2] Reactogenicity of the BNT162b2 mRNA vaccine (Pfizer-BioNTech) against COVID-19 in workers of a tertiary hospital
Palomo-Palomo, Cristina
Guerra-Estevez, Dulce
Parrado-Gonzalez, Alberto
Estaire-Gutierrez, Julia
Reyes-Malia, Miguel
Mercedes Romero-Alonso, M.
FARMACIA HOSPITALARIA, 2022, 46 (03) : 152 - 156
[3] Bibliometric Analysis of Pfizer-BioNTech (BNT162B2): A COVID-19 Vaccine
Hassan, Waseem
Ara, Amina
JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (03): : 1211 - 1229
[4] Immune thrombocytopenia associated with Pfizer-BioNTech's BNT162b2 mRNA COVID-19 vaccine
Akiyama, Hiroaki
Kakiuchi, Seiji
Rikitake, Junpei
Matsuba, Hiroyuki
Sekinada, Daisuke
Kozuki, Yoko
Iwata, Nobuko
IDCASES, 2021, 25
[5] Presumed Autoimmune Optic Neuropathy After Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine
Saffra, Norman A.
Emborgo, Trisha S.
Kelman, Shalom E.
Kirsch, David S.
JOURNAL OF NEURO-OPHTHALMOLOGY, 2024, 44 (01) : e88 - e90
[6] Pfizer-BioNTech COVID-19 Vaccine (BNT162b2) Side Effects: A Systematic Review
Dighriri, Ibrahim M.
Alhusayni, Khaled M.
Mobarki, Ahmed Y.
Aljerary, Ibrahim S.
Alqurashi, Khalid A.
Aljuaid, Fai A.
Alamri, Khalid A.
Mutwalli, Abeer A.
Maashi, Nada A.
Aljohani, Alwaleed M.
Alqarni, Abdulrahman M.
Alfaqih, Athbah E.
Moazam, Sumiya M.
Almutairi, Muath N.
Almutairi, Afnan N.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
[7] Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine
Inoue, Masatoshi
Yasue, Yu
Kobayashi, Yoichi
Sugiyama, Yutaka
BMJ CASE REPORTS, 2022, 15 (03)
[8] Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine
Bujan Bonino, Cecilia
Moreiras Arias, Noelia
Lopez-Pardo Rico, Maria
Pita da Veiga Seijo, Gabriela
Roson Lopez, Elena
Suarez Penaranda, Jose Manuel
Sanchez-Aguilar Rojas, Dolores
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (11) : E466 - E467
[9] Intracranial Hemorrhage After Pfizer-BioNTech (BNT162b2) mRNA COVID-19 Vaccination: A Case Report
Yangi, Kivanc
Demir, Doga D.
Uzunkol, Ajlan
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
[10] Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand
Walton, Muireann
Pletzer, Vadim
Teunissen, Thomas
Lumley, Thomas
Hanlon, Timothy
DRUG SAFETY, 2023, 46 (09) : 867 - 879

← 1 2 3 4 5 →